Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer ; volume:6 ; number:1 ; day:01 ; month:11 ; year:2006 ; pages:1-8 ; date:12.2006
BMC cancer ; 6, Heft 1 (01.11.2006), 1-8, 12.2006
- Urheber
-
Akaishi, Junko
- Beteiligte Personen und Organisationen
-
Onda, Masamitsu
Okamoto, Junichi
Miyamoto, Shizuyo
Nagahama, Mitsuji
Ito, Kouichi
Yoshida, Akira
Shimizu, Kazuo
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-6-260
- URN
-
urn:nbn:de:1111-2016030340050
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Akaishi, Junko
- Onda, Masamitsu
- Okamoto, Junichi
- Miyamoto, Shizuyo
- Nagahama, Mitsuji
- Ito, Kouichi
- Yoshida, Akira
- Shimizu, Kazuo
- SpringerLink (Online service)
Ähnliche Objekte (12)
Anaplastic thyroid cancer : How far can we go?
Anaplastic Thyroid Carcinoma with Ocular Then Orbital Metastases
Long-term results of radiotherapy in anaplastic thyroid cancer
Therapeutic advances in anaplastic thyroid cancer: a current perspective
Anaplastic thyroid carcinoma with chondrosarcomatous differentiation: a case report
Inhibiting ERK dimerization ameliorates BRAF-driven anaplastic thyroid cancer
Results of combined treatment of anaplastic thyroid carcinoma (ATC)
Recent advances in the management of anaplastic thyroid cancer
Outcome after intensity modulated radiotherapy for anaplastic thyroid carcinoma
The mutation profile of differentiated thyroid cancer coexisting with undifferentiated anaplastic cancer resembles that of anaplastic thyroid cancer but not that of archetypal differentiated thyroid cancer
Anaplastic thyroid cancer spheroids as preclinical models to test therapeutics
Riedel's thyroiditis masquerading as anaplastic thyroid carcinoma: a case report
Anaplastic thyroid cancer : How far can we go?
Anaplastic Thyroid Carcinoma with Ocular Then Orbital Metastases
Long-term results of radiotherapy in anaplastic thyroid cancer
Therapeutic advances in anaplastic thyroid cancer: a current perspective
Anaplastic thyroid carcinoma with chondrosarcomatous differentiation: a case report
Inhibiting ERK dimerization ameliorates BRAF-driven anaplastic thyroid cancer
Results of combined treatment of anaplastic thyroid carcinoma (ATC)
Recent advances in the management of anaplastic thyroid cancer
Outcome after intensity modulated radiotherapy for anaplastic thyroid carcinoma
The mutation profile of differentiated thyroid cancer coexisting with undifferentiated anaplastic cancer resembles that of anaplastic thyroid cancer but not that of archetypal differentiated thyroid cancer
Anaplastic thyroid cancer spheroids as preclinical models to test therapeutics
Riedel's thyroiditis masquerading as anaplastic thyroid carcinoma: a case report
Anaplastic thyroid cancer : How far can we go?
Anaplastic Thyroid Carcinoma with Ocular Then Orbital Metastases
Long-term results of radiotherapy in anaplastic thyroid cancer
Therapeutic advances in anaplastic thyroid cancer: a current perspective
Anaplastic thyroid carcinoma with chondrosarcomatous differentiation: a case report
Inhibiting ERK dimerization ameliorates BRAF-driven anaplastic thyroid cancer
Results of combined treatment of anaplastic thyroid carcinoma (ATC)
Recent advances in the management of anaplastic thyroid cancer
Outcome after intensity modulated radiotherapy for anaplastic thyroid carcinoma
The mutation profile of differentiated thyroid cancer coexisting with undifferentiated anaplastic cancer resembles that of anaplastic thyroid cancer but not that of archetypal differentiated thyroid cancer
Anaplastic thyroid cancer spheroids as preclinical models to test therapeutics